Skip to main content
. 2020 Jan 21;10:3086. doi: 10.3389/fimmu.2019.03086

Figure 6.

Figure 6

Immobilized, engineered ICOSL-Fc variants costimulate T cells when plated with sub-optimal anti-CD3. Human T cells were stimulated with a range of anti-CD3 concentrations and a constant concentration of coimmobilized ICOSL-Fc variants (40 nM). (A) CD4 and (B) CD8 T cell proliferation was monitored by CFSE dilution. Proliferation is reported as percentage of T cells divided vs. anti-CD3 concentration. (C) IFNγ production was measured by ELISA in supernatants collected at 72 h and plotted as pg/ml cytokine vs. anti-CD3 concentration. Each point represents the mean of triplicate determinations ±s.d.